Smith, Juliana
Harris, Orlando O.
Adey, Deborah
Park, Meyeon
Funding for this research was provided by:
University of California, San Francisco PKD Center of Excellence (n/a)
Article History
Received: 26 August 2022
Accepted: 18 April 2023
First Online: 1 May 2023
Declarations
:
: The authors declare that they have no competing interests. Dr. Adey research funding from Natera, Hansa, and Allovir and American Board of Internal Medicine, Specialty board of governance. Dr. Park reports consulting for Otsuka America Pharmaceutical Inc. and Natera.
: We obtained written informed consent via Docusign and also sought verbal consent from all participants before starting the interviews. No organs or tissues were procured from any participants, including prisoners. All methods were performed in accordance with the Declaration of Helsinki and approved by the Research Subjects Review Board of the University of California, San Francisco (IRB # 21-34198).
: Not applicable.